[Efficacy of bemithyl and pyrazidol in patients with cerebroasthenia due to brain injury].
The article is dedicated to therapeutic efficacy of a combination of the antihypoxant bemithyl and the antidepressant pyrazidol in patients with asthenoneurotic and asthenovegetative syndromes after moderate isolated brain injury (BI). The combined therapy was shown to reduce long-term sequences of BI such as asthenic symptoms, stabilize both lipid peroxidation processes and serum antioxidative systems.
Zarubina
I V
IV
Narmanbetova
F N
FN
Agadzhanian
E F
EF
Shabanov
P D
PD
D000293:Adolescent; D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use*; D000975:Antioxidants / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D001930:Brain Injuries / Q000150:complications*; D002227:Carbazoles / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015227:Lipid Peroxidation / Q000187:drug effects / Q000502:physiology; D008297:Male; D008875:Middle Aged; D009449:Neurocirculatory Asthenia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome
D000928:Antidepressive Agents; D000975:Antioxidants; D001562:Benzimidazoles; D002227:Carbazoles; C049825:bemethyl; C009830:pirlindole